KARYOTYPE ANALYSIS ABNORMAL

This adverse event was reported 109 times

These drugs are most commonly taken by patients reporting KARYOTYPE ANALYSIS ABNORMAL:

# Drug Count
0 LEVETIRACETAM 13
1 RITONAVIR 13
2 VENETOCLAX 13
3 DARUNAVIR 11
4 LEVETIRACETAM IN SODIUM CHLORIDE 11
5 LEVETIRACETAM INJECTION 11
6 LEVETIRACETAM ORAL 11
7 LAMOTRIGINE 10
8 DIAZEPAM 9
9 LAMOTIRIGINE 9
See all common drugs associated with KARYOTYPE ANALYSIS ABNORMAL

KARYOTYPE ANALYSIS ABNORMAL is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PIRTOBRUTINIB 5 0.0051
1 SODIUM CARBONATE 1 0.0043
2 DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE 3 0.0017
3 ZANUBRUTINIB 6 0.0013
4 IBRITUMOMAB TIUXETAN 2 0.0013
5 MECASERMIN 1 0.0012
6 LOMUSTINE 3 0.0012
7 DARUNAVIR 11 0.0007
8 BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B 1 0.0006
9 BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE 1 0.0006
See all drugs enriched for association with KARYOTYPE ANALYSIS ABNORMAL

KARYOTYPE ANALYSIS ABNORMAL is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Protease Inhibitor [EPC] 13 0.0003
1 Cytochrome P450 3A Inhibitor [EPC] 13 0.0002
2 BCL-2 Inhibitor [EPC] 13 0.0002
3 Vitamin D2 Analog [EPC] 1 0.0001
4 Iron Chelator [EPC] 4 0.0001
5 Prostaglandin E1 Analog [EPC] 2 0.0001
6 CD19-directed Chimeric Antigen Receptor [EPC] 1 0.0001
7 Sulfone [EPC] 1 0.0001
8 Barbiturate [EPC] 1 0.0001
9 Vitamin D Analog [EPC] 1 0.0001
See all drug classes enriched for association with KARYOTYPE ANALYSIS ABNORMAL